Announced Tue, 23 Jun · 17:35 IST
Bacil Pharma Board to consider fund raising on 26 June
Fund Raising View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.5%1-day move
₹40.35
prior close
₹42.39
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.2+0.3+0.3-1.5+2.1-1.9-1.4-0.9-2.3-8.6-30.1——
Up moveDown movePending
AI summary
Bacil Pharma's Board will meet on 26 June 2026 to consider raising funds through one or more options, including a preferential issue of equity shares or convertible securities, a rights issue, or any other permissible mode. The company has not disclosed the amount, pricing, or specific structure. The trading window for insiders is closed from 23 June until 48 hours after the meeting outcome is declared.
Likely market impact
Possible equity dilution ahead depending on which route the Board approves. Watch for size, pricing, and structure post-meeting.